Community perception and acceptability of COVID-19 vaccine in South-West Nigeria: an online cross-sectional study
Accepted: 25 December 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background. The development of COVID-19 vaccines holds great potential for controlling the spread of SARS-CoV-2. Vaccines, irrespective of the disease are generally fraught with hesitancy, and Nigeria has a history of vaccine hesitancy. Objective. This study aimed at determining the perception of community members about the COVID-19 vaccine and their readiness to accept the vaccine in South West, Nigeria. Methods. A descriptive cross-sectional study design was employed to collect data from consenting adults using a structured online questionnaire for a period of three weeks. Data were subjected to a Chi-square test and logistic regression for bivariate and multivariate analysis, respectively. Results. A total of 807 respondents participated in the survey with 57.7% males and 42.3% females. Forty-five respondents (5.6%) had previously been diagnosed with COVID-19 while 11.5% of the respondents had co-morbidity. The overall perception of COVID-19 vaccines was good. Fifty-nine (59%) percent of the respondents were willing to accept the vaccine and will also encourage their family members to take the vaccine. Vaccine origin and cost were determinants of vaccine acceptability. Nonacceptability of the vaccine (61.6%) was based on possible adverse effects of the vaccine and mistrust of the government. Educational level, skill status, type of employment, and sector of employment were associated (P<0.001) with the acceptability of the COVID-19 vaccine. Conclusions. Citizens were willing to take COVID-19 vaccines, however, a lack of trust in government programs might undermine the vaccine campaign. Hence, the government needs to rebuild trust with the citizens towards achieving a high vaccination rate for COVID-19.
Ge H, Wang X, Yuan X, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39:1011–19
Zhu N, Zhang D, Wang W, et al. China novel coronavirus.investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382:727-33
World Health Organization. Coronavirus disease 2019 (COVID-19): Situation Report –38.27 February 2020. www.who.int/docs/default-source/coronaviruse/situation-reports/20200227-sitrep-38-COVID19.pdf?sfvrsn=9f98940c_2. Accessed 28 November 2020
WHO Director-General’s opening remarks at the media briefing on COVID19 -March 2020. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-COVID-19---11-march-2020. Accessed 19 November 2020
Nigeria Centre for Disease Control. (2020). COVID-19 Nigeria. https://COVID19.ncdc.gov.ng/report.Accessed 22 November 2020
WHO April 2020 COVID-19 Strategy Update. https://www.who.int/docs/default-source/coronaviruse/COVID-strategy-update-14april2020.pdf. Accessed 22 November 2020
Calina, D, Docea AO, Petrakis D, et al. A. Towards effective COVID 19 vaccines: updates, perspectives and challenges (Review). Int J Mol Med. 2020;46:3-16.
Hodgson SH, Mansatta, K, Mallett, G et al. What defines an efficacious COVID-19 vaccine? a review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2020;21:e26-35.
Omer SB, Yildirim I, Forman HP. Herd immunity and implications for SARS-CoV-2 control. JAMA. 2020; 324:2095–96
WHO. Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_20Jan2021_v2.pdf. Accessed 5 July 2021
Amzat J, Aminu K, Kolo VI, et al. Coronavirus outbreak in Nigeria: burden and socio-medical response during the first 100 days. Int J Infect Dis. 2020;98:218-4.
WHO Working Group – Target product profiles for COVID-19 vaccines. https://www.who.int/publications/m/item/who-working-group-target-product-profiles-for-COVID-19-v. Accessed 27 November 2020
Arthur C Evans. 2020. For a COVID-19 Vaccine to succeed, look to behavioral research. https://www.apa.org/news/press/op-eds/COVID-19-vaccine-research. Accessed 27 November 2020
Head KJ, Kasting ML, Sturm LA, et al. A national survey assessing SARS-CoV-2 vaccination intentions: implications for future public health communication efforts. Sci Commun. 2020;42:698–723
Butler R, MacDonald M.E. SAGE working group on Vaccine hesitancy. Diagnosing the determinants of Vaccine Hesitancy in specific subgroups: The guide to tailoring immunization programmes (TIP). Vaccine. 2015;33:4176-9
WHO. Ten Threats to Global Health in 2019. https://www.who.int/vietnam/news/feature-stories/detail/ten-threats-to-global-healthin-2019. Accessed 20 November 2020
National Agency for Food and Drug Administration and Control. https://www.nafdac.gov.ng/ Accessed 5 July 2021
Nigeria Bureau of Statistics 2017. https://www.nigerianstat.gov.ng/. Accessed 17 November 2020.
Adebisi YA, Alaran AJ, Bolarinwa OA, et al. When it is available, will we take it? Social media users' perception of hypothetical COVID-19 vaccine in Nigeria. Pan Afr Med J. 2021;38:230.
Eniade OD, Olarinmoye A, Otovwe A, et al. Willingness to accept COVID-19 vaccine and its determinants among Nigeria citizens: A web-based cross-sectional study. JAMMR. 2021;33:13-22.
Mousari SH. Mapping the changes on incidence, case fatality rates and recovery proportion of COVID 19 in Afghanistan using geographical information systems. Arch Med Res. 2020;51:363-74
Sundar R, R. Gayathri, V. Vishnu Priya, S. Kavitha. Knowledge, awareness and perception on the prevention and cure for COVID-19 among dental students - a survey. Ann Romanian Soc Cell Biol. 2021;25:1154–70.
Enitan SS, Oyekale AO, Akele RY, et al. Assessment of knowledge, perception and readiness of Nigerians to participate in the COVID-19 vaccine trial. Int J Vaccine Immunizat. 2020;4
Ogbomo O. Factors associated with the myth about COVID -19 pandemic in SubSaharan Africa. J Glob. Health. 2020;4:e2020094
Tobin EA, Okonofua M, Adeke A, Obi A. Willingness to accept a COVID-19 vaccine in Nigeria: A population-based cross-sectional study. CAJPH. 2021;7:53-60
Olomofe CO, Soyemi KV, Udomah BF, et al. Predictors of uptake of a potential COVID-19 vaccine among Nigerian adults. J Vaccines Vaccin. 2021;12:442
Akinyemi PA, Fajobi O, Owoade IA, et al. Community perception and determinants of willingness to uptake COVID-19 vaccines among residents of Osun State, South-West Nigeria. Int J Community Med Public Health. 2021;8:1551-7
Boyon N. Three in four adults globally say they would get a vaccine for COVID-19. https://www.ipsos.com/en/three-four-adults-globally-say-theyd-get-vaccine-COVID-19. Accessed 13 June 2021
Islam MS, Siddique AB, Akter R, et al. Knowledge, attitudes and perceptions towards COVID-19 vaccinations: a cross-sectional community survey in Bangladesh. BMC Public Health. 2021;21:1851.
Copyright (c) 2023 the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.